Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis

Clinical Immunology

Volumn 139, Issue 2, 2011, Pages 177-184

  El Asrar, Ahmed M Abu ^a   Struyf, Sofie ^b   Kangave, Dustan ^a   Al Obeidan, Saleh S ^a   Opdenakker, Ghislain ^b   Geboes, Karel ^c   Van Damme, Jo ^b  

^a KING ABDUL AZIZ UNIVERSITY HOSPITAL   (Saudi Arabia)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Beh et's disease; Cytokines; HLA B27; Uveitis; Vogt Koyanagi Harada disease

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 17; TUMOR NECROSIS FACTOR ALPHA;

AQUEOUS HUMOR; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; HUMAN; IMMUNE RESPONSE; INFLAMMATION; PRIORITY JOURNAL; TREATMENT OUTCOME; UVEITIS;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AQUEOUS HUMOR; BEHCET SYNDROME; CYCLOSPORINE; CYTOKINES; FEMALE; HLA-B27 ANTIGEN; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-15; INTERLEUKIN-17; LOGISTIC MODELS; MALE; MIDDLE AGED; TH1 CELLS; TH17 CELLS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS; UVEOMENINGOENCEPHALITIC SYNDROME; YOUNG ADULT;

EID: 79954585467     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2011.01.014     Document Type: Article

References (35)

1. Imai Y., Ohno S. Helper T-cell subsets in uveitis. Int. Ophthalmol. Clin. 2002, 42:25-32.
2. Mosmann T.R., Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol. 1989, 7:145-173.
3. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., Weaver C.T. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005, 6:1123-1132.
4. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005, 6:1133-1141.
5. Bettelli E., Korn T., Oukka M., Kuchroo V.K. Induction and effector functions of TH17 cells. Nature 2008, 453:1051-1057.
6. Dardalhon V., Korn T., Kuchroo V.K., Anderson A.C. Role of Th1 and Th17 cells in organ-specific autoimmunity. J. Autoimmun. 2008, 31:252-256.
7. Pernis A.B. Th17 cells in rheumatoid arthritis and systemic lupus erythematosus. J. Intern. Med. 2009, 265:644-652.
8. Martinez G.J., Nurieva R.I., Yang X.O., Dong C. Regulation and function of proinflammatory TH17 cells. Ann. NY. Acad. Sci. 2008, 1143:188-211.
9. Lubberts E. Th17 cytokines and arthritis. Semin Immunopathol 2010, 32:43-53.
10. Oukk M. Th17 cells in immunity and autoimmunity. Ann. Rheum. Dis. 2008, 67:26-29.
11. O'Shea J.J., Ma A., Lipsky P. Cytokines and autoimmunity: Nat. Rev. Immunol. 2002, 2:37-45.
12. International Study Group for Behçet's disease Criteria for diagnosis of Behçet's disease. Lancet. 1990, 335:1078-1080.
13. Read R.W., Holland G.N., Rao N.A., Tabbara K.F., Ohno S., Arellanes-Garcia L., Pivetti-Pezzi P., Tessler H.H., Usui M. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am. J. Ophthalmol. 2001, 131:647-652.
14. Standardization of Uveitis Nomenclature (SUN) Working Group: Standardization of uveitis nomenclature for reporting clinical data: results of the first international workshop. Am. J. Ophthalmol. 2005; 140:509-516.
15. Luger D., Silver P.B., Tang J., Cua D., Chen Z., Iwakura Y., Bowman E.P., Sgambellone N.M., Chan C.C., Caspi R.R. Either a Th 17 or a Th1 effector response can drive autoimmunity: Conditions of disease induction affect dominant effector category. J. Exp. Med. 2008, 205:799-810.
16. Hohki S., Oguro N., Haruta H., Nakai K., Terabe F., Serada S., Fujimoto M., Nomura S., Kawahata H., Kishimoto T., Naka T. Blockade of interleulin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses. Exp. Eye Res. 2010, 91:162-170.
17. Yoshimura T., Sonoda K.H., Miyazaki Y., Iwakura Y., Ishibashi T., Yoshimura A., Yoshida H. Differential roles for IFN-γ and IL-17 in experimental autoimmune uveoretinitis. Int. Immunol. 2007, 20:209-214.
18. Zhang R., Qian J., Yuan Y.F., Xue K. Suppression of experimental autoimmune uveoretinitis by anti-IL-17 antibody. Curr. Eye Res. 2009, 34:297-303.
19. Ahn J.K., Yu H.G., Chung H., Park Y.G. Intraocular cytokine environment in active Behçet's uveitis. Am. J. Ophthalmol. 2006, 142:429-434.
20. Abu El-asrar A.M., Struyf S., Descamps F.J., Al-Obeidan S.A., Proost P., Van Damme J., Opdenakker G., Geboes K. Chemokines and gelatinases in the aqueous humor of patients with active uveitis. Am. J. Ophthalmol. 2004, 138:401-411.
21. Fehniger T.A., Caligiuri M.A. Interleukin 15: biology and relevance to human disease. Blood 2001, 97:14-32.
22. Waldmann T.A. Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune disease. Arthritis Res. Ther. 2004, 6:174-177.
23. Vassalli P. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 1992, 10:411-452.
24. Abu El-Asrar A.M., Abboud E.B., Aldibhi H., Al-Arfaj A. Long-term safety and efficacy of infliximab therapy in refractory uveitis due to Behçet's disease. Int. Ophthalmol. 2005, 26:83-92.
25. Asadullah K., Sterry W. Volk HD: Interleukin-10 therapy. Review of a new approach. Pharmacol. Rev. 2003, 55:241-269.
26. O'Garra A., Vieira P.L., Vieira P., Goldfeld A.E. IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J. Clin. Invest. 2004, 114:1372-1378.
27. Rizzo L.V., Xu H., Chan C.C., Wiggert B., Caspi R.R. IL-10 has a protective role in experimental autoimmune uveoretinitis. Int. Immunol. 1998, 10:807-814.
28. Rosenbaum J.T., Angell E. Paradoxial effects of IL-10 in endotoxin-induced uveitis. J. Immunol. 1995, 155:4090-4094.
29. Fang I.M., Lin C.P., Yang C.H., Chiang B.L., Yang C.M., Chau L.Y., Chen M.S. Inhibition of experimental autoimmune anterior uveitis by adenovirus-mediated transfer of the interleukin-10 gene. J. Ocul. Pharmacol. Ther. 2005, 21:420-428.
30. Mashimo H., Ohguro N., Nomura S., Hashida N., Nakai K., Tano Y. Neutrophil chemotaxis and local expression of interleukin-10 in the tolerance of endotoxin-induced uveitis. Invest. Ophthalmol. Vis. Sci. 2008, 49:5450-5457.
31. Xu Y., Chen W., Lu H., Hu X., Li S., Wang J., Zhao L. The expression of cytokines in the aqueous humor and serum during endotoxin-induced uveitis in C3H/HeN mice. Mol. Vis. 2010, 16:1689-1695.
32. Takase H., Futagami Y., Yoshida T., Kamoi K., Sugita S., Imai Y., Mochizuki M. Cytokine profile in aqueous humor and sera of patients with infectious or noninfectious uveitis. Invest. Ophthalmol. Vis. Sci. 2006, 47:1557-1561.
33. Sijssens K.M., Rijkers G.T., Rothova A., Stilma J.S., Schellekens P.A., de Boer J.H. Cytokines, chemokines and soluble adhesion molecules in aqueous humor of children with uveitis. Exp. Eye Res. 2007, 85:443-449.
34. Remmers E.F., Cosan F., Kirino Y., Ombrello M.J., Abaci N., Satorius C., Le J.M., Yang B., Korman B.D., Cakiris A., Aglar O., Emrence Z., Azakli H., Ustek D., Tugal-Tutkun I., Akman-Demir G., Chen W., Amos C.I., Dizon M.B., Kose A.A., Azizlerli G., Erer B., Brand O.J., Kaklamani V., Kaklamanis P., Ben-Chetrit E., Stanford M., Fortune F., Ghabra M., Ollier W.E.R., Cho Y.H., Bang D., O'Shea J., Wallace G.R., Gadina M., Kastner D.L., Gül A. Genome-wide association study identifies variants in the MCH class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease. Nat. Genet. 2010, 42:698-702.
35. Mizuki N., Meguro A., Ota M., Ohno S., Shiota T., Kawagoe T., Ito N., Kern J., Okada E., Yatsu K., Song Y.W., Lee E.B., Kitaichi N., Namba K., Horie Y., Takeno M., Sugita S., Mochizuki M., Bahram S., Ishigatsubo Y., Inoko H. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat. Genet. 2010, 42:703-707.